Age and African-American race impact the validity and reliability of the asthma control test in persistent asthmatics

Research - Open Access
Allison J. BurbankKrista TodoricPamela SteeleJonathan RosenHaibo ZhouMarcia FryeCeila E. LoughlinSally IvinsKatherine MillsLauren Dembicki MasseyBryce B. Reeve and Michelle L. Hernandez

Abstract

Background

The Asthma Control Test (ACT) is widely used to assess asthma control, yet the validity and reliability of the test have not been specifically evaluated in adolescents or African-Americans. We conducted a prospective psychometric study of the ACT in African-American (AA) and non-African-American (nAA) adolescents with persistent asthma, with emphasis on the clinical utility of the test for medical decision making.

Methods

Participants completed the ACT and performed spirometry. A physician conducted a guidelines-based assessment of asthma control, blinded to the ACT score. Study procedures were repeated 6–8 weeks later. The ACT-based asthma control assessment was compared to physician assessment.

Results

For baseline and follow-up visits, internal consistency, as measured using Cronbach’s alpha, was 0.80 and 0.81 in AA teens and 0.80 and 0.83 in nAA teens. Intraclass correlation coefficients were 0.59 and 0.76 in AA and nAA teens, respectively, with stable asthma control over time. Agreement between ACT and physician assessment was moderate in AA teens and fair in nAA teens. An ACT score of ≤19 showed reduced sensitivity for not well controlled asthma in both groups, while a score of ≤21 had the greatest area under the ROC curve. ACT scores were marginally responsive to change in control status.

Conclusions

Concerns for the ACT’s ability to detect uncontrolled asthma in adolescents emphasizes the need for a more comprehensive evaluation of asthma control in clinical settings. A higher threshold ACT score to define not well controlled asthma may be needed if the ACT is to be used for medical decision making.

Download PDF

 

 

(You must be logged in to add and reply comments)

Interasma on Twitter

Interasma RT @Aller_MD: Subcutaneous immunotherapy induces alterations in monocytes and dendritic cells homeostasis in allergic rhinitis patients htt…
1hreplyretweetfavorite
Interasma RT @Aller_MD: Top story: @SeattleMamaDoc: '“Air Canada doesn’t have epi on board” (apparently too expensive - huh). Thankfully most food-al…
1hreplyretweetfavorite
Interasma Interasma - Effects of Macrolide Treatment during the Hospitalization of Children with Childhood Wheezing Disease:… https://t.co/XLMhnvQl5E
3hreplyretweetfavorite
Interasma RT @ARIAGuideline: Towards precision medicine in chronic rhinosinusitis. Prof. Dr. Benjamin Bleier, USA. https://t.co/ps5LKfOD6H
8hreplyretweetfavorite
Interasma RT @ARIAGuideline: First-line and second-line treatments for chronic sinusitis. An interview with Prof. Peter Hellings, Belgium https://t.c…
8hreplyretweetfavorite

Editor: Juan C. Ivancevich, MD

Copyright © Interasma 2003-2017  •  Terms of Use  •  Privacy Policy  •  Contact Us  •  Sitemap

Powered by FREI SA

InterAsma